SOW
CRNX icon

State of Wyoming’s Crinetics Pharmaceuticals CRNX Stock Holding History

State of Wyoming’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-669
Closed -$31.1K – 1843
2025
Q4 		$31.1K Sell
669
-307
-31% -$13.7K ﹤0.01% 1636
2025
Q3 		$40.6K Buy
976
+225
+30% +$7.19K ﹤0.01% 1620
2025
Q2 		$21.6K Sell
751
-319
-30% -$9.85K ﹤0.01% 1703
2025
Q1 		$35.9K Buy
1,070
+85
+9% +$3.17K ﹤0.01% 1536
2024
Q4 		$50.4K Buy
+985
New +$55.1K 0.01% 1426
2022
Q3 		– Sell
-70
Closed -$1K – 1601
2022
Q2 		$1K Buy
70
+17
+32% +$339 ﹤0.01% 1804
2022
Q1 		$1K Buy
53
+3
+6% +$61 ﹤0.01% 1732
2021
Q4 		$1K Sell
50
-2
-4% -$49 ﹤0.01% 1801
2021
Q3 		$1K Hold
52
– – ﹤0.01% 1173
2021
Q2 		$1K Buy
+52
New +$914 ﹤0.01% 1128

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

State of Wyoming's CRNX Position: Q1 2026 in Review

State of Wyoming sold out of Crinetics Pharmaceuticals (CRNX) in Q1 2026, closing a stake of 669 shares — an estimated $31.1K sold.

State of Wyoming first reported a position in CRNX in Q2 2021 and held it in 10 quarters. The position peaked at $50.4K in Q4 2024. 243 funds tracked by Wall St. Rank hold CRNX as of Q1 2026.

  • State of Wyoming reported no remaining Crinetics Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • State of Wyoming sold 669 Crinetics Pharmaceuticals shares in Q1 2026, an estimated $31.1K.
  • State of Wyoming first reported a position in Crinetics Pharmaceuticals in Q2 2021 and held it in 10 quarters.
  • State of Wyoming's Crinetics Pharmaceuticals position peaked at $50.4K in Q4 2024.
  • 243 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.